Literature DB >> 11804262

Ketoconazole and Flutamide in the treatment of disseminated intravascular clotting from prostate cancer: a case report and review.

S Chakrapee-Sirisuk1, K Amornpichetkul, S Visudhiphan, T Sangruchi, V Srimuninnimit, P Sinlarat.   

Abstract

Disseminated intravascular clotting (DIC) is a well-recognized complication of malignancy. Prostatic cancer can produce chronic DIC as well as acute severe DIC. Treatment of DIC are general supportive measures including heparin, transfusion of blood, platelets and clotting factors, but the most important aspect is correction of underlying malignant diseases i.e. cancer of the prostate gland. For metastatic prostatic cancer presenting with an emergency oncologic condition, the treatment of choice is surgical orchiectomy, but surgery may not be possible in the presence of severe DIC. Ketoconazole and Flutamide are drugs with different mechanisms for hormonal manipulation of this cancer. Due to severe DIC, we combined both drugs trying to put maximum therapeutic effect on this life threatening profound DIC patient.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11804262

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  4 in total

1.  Prostate cancer: beware of disseminated intravascular coagulation.

Authors:  Mihir Desai; Babbin John; Gillian Evans; Ben Eddy
Journal:  BMJ Case Rep       Date:  2015-03-27

2.  Disseminated Intravascular Coagulation as an Initial Manifestation of Metastatic Prostate Cancer Emergently Treated with Docetaxel-Based Chemotherapy.

Authors:  Kavita Agrawal; Nirav Agrawal; Levin Miles
Journal:  Case Rep Oncol Med       Date:  2019-04-24

3.  Search for a cause of disseminated intravascular coagulopathy resulted in finding metastatic prostate cancer.

Authors:  Mohammad Forat Yazdi; Golnaz Malekzadeh
Journal:  Cent European J Urol       Date:  2013-08-13

4.  Prostate Cancer-Associated Disseminated Intravascular Coagulation with Excessive Fibrinolysis Treated with Degarelix.

Authors:  Shawn Y Ong; Josephine Taverna; Clint Jokerst; Thomas Enzler; Emad Hammode; Elisa Rogowitz; Myke R Green; Hani M Babiker
Journal:  Case Rep Oncol Med       Date:  2015-11-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.